GLNMX
Price
$25.24
Change
+$0.10 (+0.40%)
Updated
Jul 3 closing price
Net Assets
76.12M
RSLDX
Price
$74.01
Change
+$0.43 (+0.58%)
Updated
Jul 3 closing price
Net Assets
78.69B
Interact to see
Advertisement

GLNMX vs RSLDX

Header iconGLNMX vs RSLDX Comparison
Open Charts GLNMX vs RSLDXBanner chart's image
MFS Global New Discovery R4
Price$25.24
Change+$0.10 (+0.40%)
VolumeN/A
Net Assets76.12M
American Funds SMALLCAP World R5E
Price$74.01
Change+$0.43 (+0.58%)
VolumeN/A
Net Assets78.69B
GLNMX vs RSLDX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GLNMX vs. RSLDX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLNMX is a Buy and RSLDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 78.7B vs. GLNMX (76.1M). RSLDX pays higher dividends than GLNMX: RSLDX (0.81) vs GLNMX (0.56). GLNMX was incepted earlier than RSLDX: GLNMX (14 years) vs RSLDX (10 years). GLNMX (1.56) is less costly to investors than RSLDX (0.80). GLNMX is a more actively managed with annual turnover of: 37.00 vs. RSLDX (32.00). GLNMX has a lower initial minimum investment than RSLDX: GLNMX (0) vs RSLDX (250). GLNMX annual gain was more profitable for investors over the last year : 12.37 vs. RSLDX (10.63). GLNMX return over 5 years is better than : 26.57 vs. RSLDX (22.93).
GLNMXRSLDXGLNMX / RSLDX
Total Expense Ratio1.100.80138%
Annual Report Gross Expense Ratio1.560.80195%
Fund Existence14 years10 years-
Gain YTD10.3128.730118%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets76.1M78.7B0%
Annual Yield % from dividends0.560.8170%
Returns for 1 year12.3710.63116%
Returns for 3 years37.0335.76104%
Returns for 5 years26.5722.93116%
Returns for 10 years65.55N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAGN13.180.11
+0.84%
Magnera Corporation
GLMD1.830.02
+0.83%
Galmed Pharmaceuticals Ltd
LGND114.580.92
+0.81%
Ligand Pharmaceuticals
SWKS78.760.58
+0.74%
Skyworks Solutions
BCAX9.03-0.17
-1.85%
Bicara Therapeutics Inc.